Merger Proposal

edit

As somebody mentioned a year ago in the other talk page, this is a pretty obvious merge. TachyonJack (talk) 20:15, 3 April 2013 (UTC)Reply

Imported talk page sections from Talk:Wakefulness-promoting agent

edit

Proposed merge

edit

There is no reason that this article should not be merged with the article on Eugeroics as that is the name of the category in the Stimulant box. — Preceding unsigned comment added by 207.251.103.42 (talk) 20:13, 2 March 2012 (UTC)Reply

I have completed the merge and, as per WP:COMMONNAME merged into this article. LT90001 (talk) 03:35, 9 October 2013 (UTC)Reply

Drug Examples 2C-G-N removed

edit

The text removed is found below

Other drugs:


Given that this is described to have amphetamine like effects, and was only synthesized and tested by a very small group of individuals, it is very dubious to have this stated as an example of a eugeroic. The description that this compound is amphetamine like, on its page, should be enough to warrant removal as the whole point of wakefulness promoting agents is to NOT have such effects.

User: inthedryer

orexin

edit

moved here per WP:PRESERVE as this was unsourced:

The main mechanism of action of wakefulness enhancers(eugeroics) come from activation of orexin receptors(orexin receptor agonist), which causes an increase in histamine levels.

The functional opposites of wakefulness-promoting agents are hypnotics, such as centrally-acting antihistamines (H1 receptor antagonists) and suvorexant, an orexin receptor antagonist.

-- Jytdog (talk) 16:14, 29 November 2016 (UTC)Reply